Advertisement

Topics

Teva Pharmaceutical Industries Ltd. Company Profile

01:43 EDT 20th September 2017 | BioPortfolio

When: Wednesday, June 2, 2010 at 10:30 AM (local UK time)


News Articles [1648 Associated News Articles listed on BioPortfolio]

Brokerages Expect Teva Pharmaceutical Industries Limited (TEVA) to Post $1.08 EPS

Wall Street brokerages predict that Teva Pharmaceutical Industries Limited will report earnings per share of $1.08 for the current fiscal quarter, according to Zacks . Five analysts have provided esti...

$1.10 Earnings Per Share Expected for Teva Pharmaceutical Industries Limited (NYSE:TEVA) This Quarter

Brokerages expect that Teva Pharmaceutical Industries Limited will report $1.10 earnings per share for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Tev...

Brokerages Anticipate Teva Pharmaceutical Industries Limited (TEVA) to Post $1.10 Earnings Per Share

Wall Street brokerages expect Teva Pharmaceutical Industries Limited to announce earnings of $1.10 per share for the current quarter, according to Zacks . Five analysts have made estimates for Teva Ph...

Brokerages Anticipate Teva Pharmaceutical Industries Ltd (TEVA) Will...

Analysts forecast that Teva Pharmaceutical Industries Ltd will report sales of $5.84 billion for the current quarter, according to Zacks . Five analysts have provided estimates for Teva Pharmaceutical...

Teva Pharmaceutical Industries Limited (TEVA) Expected to Announce Quarterly Sales of $5.85 Billion

Wall Street analysts expect that Teva Pharmaceutical Industries Limited will report $5.85 billion in sales for the current quarter, Zacks Investment Research reports. Five analysts have provided estim...

BidaskClub Upgrades Teva Pharmaceutical Industries Limited (TEVA) to Sell

Several other research analysts have also recently weighed in on the stock. Cantor Fitzgerald set a $31.00 price target on shares of Teva Pharmaceutical Industries Limited and gave the company a "hold...

Teva Pharmaceutical Industries Ltd (TEVA) Issues Earnings Results, Meets Expectations

Teva Pharmaceutical Industries Ltd issued its quarterly earnings data on Thursday. The company reported $1.06 EPS for the quarter, meeting the consensus estimate of $1.06.

Teva Pharmaceutical Industries Limited (TEVA) Sets New 1-Year Low at $15.57

Teva Pharmaceutical Industries Limited 's share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $15.57 and last traded at $15.60, with a volume of 10,960...

Drugs and Medications [690 Associated Drugs and Medications listed on BioPortfolio]

Lithium carbonate [Sun Pharmaceutical Industries Limited ]

Lithium Carbonate Tablets USP

Epinastine hydrochloride [Sun Pharmaceutical Industries Limited ]

Epinastine Hydrochloride Ophthalmic Solution 0.05%Sterile

Dawnmist hypoallergenic petroleum [Donovan Industries, Inc.]

DawnMist Hypoallergenic Petroleum Jelly

Purell advanced green certified instant hand sanitizer [GOJO Industries, Inc.]

PURELL Advanced Green CertifiedInstant Hand Sanitizer Foam

Purell advanced green certified instant hand sanitizer [GOJO Industries, Inc.]

PURELL Advanced Green CertifiedInstant Hand Sanitizer

PubMed Articles [615 Associated PubMed Articles listed on BioPortfolio]

Assessment of upper limb musculoskeletal pain and posture in workers of packaging units of pharmaceutical industries.

Work-related musculoskeletal disorders are defined as the disabling or painful injury to the muscles, nerves or tendons that are caused by work or aggravated by it. Some studies confirm the associatio...

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1.

Three-dimensional printing quickly became a standard tool in the automotive, aerospace, and consumer goods industries and, recently, has begun gaining traction in pharmaceutical manufacturing. 3D prin...

Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae from Pharmaceutical Wastewaters in South-Western Nigeria.

Emergence and spread of Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases (ESBLs) present a major threat to public health. In this study, we characterized β-lactam-resistant K....

Generation of quercetin/cellulose acetate phthalate systems for delivery by supercritical antisolvent process.

Supercritical antisolvent process (SAS) has been used to precipitate microparticles of quercetin, a plant pigment found in many foods and used for medical treatments, pharmaceutical and cosmetic indus...

High-Throughput Automation in Chemical Process Development.

High-throughput (HT) techniques built upon laboratory automation technology and coupled to statistical experimental design and parallel experimentation have enabled the acceleration of chemical proces...

Clinical Trials [310 Associated Clinical Trials listed on BioPortfolio]

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

The objective of this study is to evaluate the comparative bioavailability between tamsulosin hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.; distribute...

Lansoprazole 30 mg DR Capsule Fasting Study

The object of this study is to compare the relative bioavailability of lansoprazole 30 mg delayed-release capsules (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by ...

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

The study will compare the relative bioavailability (rate and extent of absorption) of 200 mg/5 mL Azithromycin oral suspension manufactured by TEVA Pharmaceutical Industries Ltd.; distrib...

Leflunomide 20 mg Tablets, Non-Fasting

The objective of this study is to compare the relative bioavailability of leflunomide 20 mg tablets (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by TEVA Pharmaceut...

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

The object of this study is to compare the relative bioavailability of lansoprazole 30 mg delayed-release capsules (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by ...

Companies [2145 Associated Companies listed on BioPortfolio]

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals and active pharmaceu...

Teva Neuroscience, Inc.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops,...

Teva Neuroscience Inc.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and...

Teva USA

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and ...

Teva Respiratory, a subsidiary of Teva Pharmaceutical Industries Ltd.

More Information about "Teva Pharmaceutical Industries Ltd." on BioPortfolio

We have published hundreds of Teva Pharmaceutical Industries Ltd. news stories on BioPortfolio along with dozens of Teva Pharmaceutical Industries Ltd. Clinical Trials and PubMed Articles about Teva Pharmaceutical Industries Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Teva Pharmaceutical Industries Ltd. Companies in our database. You can also find out about relevant Teva Pharmaceutical Industries Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record